Dr. Rivella is an expert in the pathophysiology of erythroid and iron disorders and in the generation of lentiviral vectors for the cure of hemoglobinopathies. He also investigates additional disorders such as anemia of inflammation and hemochromatosis.
Pioneering new approaches to diagnosis, care, and treatment for patients with red blood cell disorders with novel gene therapies and stem-cell-based treatments that aim to reduce symptoms and prolong life.
The focus of the Chou Laboratory is to investigate the mechanisms of normal hematopoietic development, understand how these become disrupted in hematologic diseases, and create novel tools using induced pluripotent stem cells (iPSCs) to model blood diseases and improve treatment.
What happens when you combine curiosity, families, and science and technology? You’d know the answer to that question and lots more if you attended the Philadelphia Science Festival, a massive science carnival held over nine days featuring hands-on experiments and demonstrations that showcased how science connects to our everyday lives.